CLC Number:
| [1] Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome[J]. Arthritis Rheumatol, 2014, 66(9): 2613-2620. [2] Panchal N, Booth C, Cannons JL, et al. X-linked lymphoproliferative disease type 1: a clinical and molecular perspective[J]. Front Immunol, 2018, 9: 666. [3] Williams H, Crawford D. Epstein-Barr virus:the impact of scientific advances on clinical practice[J]. Blood,2006,107(3):862-869. [4] Sumegi J, Huang D, Lanyi A, et al. Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease[J]. Blood, 2000, 96(9): 3118-3125. [5] Booth C, Gilmour KC, Veys P, et al. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations,management and outcome of the disease[J].Blood, 2011, 117(1): 53-62. [6] Seemayer TA, Gross TG, Egeler RM, et al. X-linked lymphoproliferative disease: twenty-five years after the discovery[J]. Pediatr Res,1995,38(4):471-478. [7] Tabata Y, Villanueva J, Lee SM, et al. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members[J]. Blood, 2005, 105(8): 3066-3071. [8] Shinozaki K, Kanegane H, Matsukura H, et al. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection[J]. Int Immunol, 2002, 14(10): 1215-1223. [9] An YF, Luo XB, Yang X, et al. Clinical and molecular characteristics of Chinese patients with X-linked lymphoproliferative syndrome type 1[J]. Pediatr Blood Cancer, 2014, 61(11): 2043-2047. [10] Ueda I, Ishii E, Morimoto A, et al. Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis(FHL)[J]. Pediatr Blood Cancer, 2006, 46(4): 482-488. [11] Zhang J, Sun Y, Shi X, et al. Genotype characteristics and immunological indicator evaluation of 311 hemophagocytic lymphohistiocytosis cases in China[J]. Orphanet J Rare Dis, 2020, 15(1): 112. [12] Wang Y, Huang W, Hu L, et al. Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis[J]. Blood, 2015, 126(19): 2186-2192. |
| [1] | HAN Kangkang, CUI Liwei, PENG Cheng, XUE Yuwen, XIAO Wei. Multiple serous effusion complicated with Warburg effect: a case report of diffuse large B-cell lymphoma and literature review [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 80-87. |
| [2] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(10): 111-112. |
| [3] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(2): 109-112. |
| [4] |
FANG Xiaosheng， LIU Xin， WANG Xin . Expressions of heat shock protein 70 and 90α in nonHodgkin′s lymphoma and its clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(04): 83-86. |
|
||
